Isracann Signs Cannabis Importation LOI with Major Israeli Manufacturer Canadian Export Product Aim to Help Reduce Shortages in Medical Supply Chain
March 03, 2021 09:00 ET | Source: Isracann Biosciences Inc. Isracann Biosciences Inc.
VANCOUVER, British Columbia, March 03, 2021 (GLOBE NEWSWIRE)
Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer/distributor is pleased to announce it has entered a non-binding Letter of Intent (LOI) outlining an importation sales agreement with a major Israeli medical cannabis company.
The proposed relationship is with one of the leading cannabis product manufacturers in Israel, who for commercial reasons can not be identified at this time. Imported goods will consist of premium Canadian cannabis via Isracann’s agreement with Costa Canna Group’s c